Minimal Residual Disease MRD Analysis for B ALL Test
Introduction to the Test
The Minimal Residual Disease (MRD) Analysis for B ALL Test is a critical diagnostic procedure used to detect the presence of residual leukemia cells in patients diagnosed with B-cell Acute Lymphoblastic Leukemia (B ALL). This test is essential for oncologists to determine the effectiveness of treatment and to monitor for potential relapse of the disease.
What the Test Measures
This test utilizes advanced Flow Cytometry techniques to identify and quantify specific cell markers associated with leukemia. The components measured include:
- CD10
- CD13
- CD15
- CD19
- CD20
- CD33
- CD34
- CD38
- CD45
- CD58
- CD73
- CD86
- CD123
- CD200
- SYTO-16
Who Should Consider This Test?
This test is recommended for patients diagnosed with B ALL, particularly those who:
- Are undergoing treatment and require monitoring for residual disease.
- Have completed treatment and need assessment for potential relapse.
- Show symptoms of leukemia or have risk factors such as family history of blood cancers.
Benefits of Taking the Test
The MRD Analysis provides several benefits for patients and healthcare providers:
- Early detection of disease recurrence, allowing for timely intervention.
- Assessment of treatment response, guiding future therapeutic decisions.
- Improved patient management and outcomes through personalized treatment plans.
Understanding Your Results
Results from the MRD Analysis will indicate the presence and quantity of residual leukemia cells. A lower level of residual disease is associated with a better prognosis. It is essential to discuss the results with your oncologist to understand their implications for your treatment plan.
Test Name and Price
| Discount Price | Regular Price |
|---|---|
| 28,000 KSh | 38,000 KSh |
Sample Collection and Instructions
For this test, a sample of 3 mL (1 mL minimum) of first-pull bone marrow aspirate is required, collected in a green top (Sodium Heparin) tube. The sample should be shipped immediately at a temperature of 18-22°C and must not be frozen. It is mandatory to provide the date and time of sampling, previous immunophenotype report, and clinical history.
Available Across Kenya
DNA Labs Kenya has branches in all major cities, ensuring easy access to this vital test. We also offer a home sample collection service for your convenience.
Book Your Test Today!
Don’t wait to ensure your health. Book the Minimal Residual Disease MRD Analysis for B ALL Test today! Call or WhatsApp us at +254711564616.
